Decibel Therapeutics, Inc.
Pharmaceutical company · Boston, Massachusetts, United States
Decibel Therapeutics, Inc. is a pharmaceutical company headquartered in Boston, Massachusetts, United States. Its earliest recorded incorporation is in 2013. It has reported private securities offerings to the US SEC, most recently $55 million sold in a notice filed in 2020.
Decibel Therapeutics at a glance
What does Decibel Therapeutics do?
Private fundraising reported to the SEC
3 Form D notices; the most recent reported $54.8 million sold (2020).
Frequently asked questions about Decibel Therapeutics
Where is Decibel Therapeutics headquartered?
Decibel Therapeutics, Inc. is headquartered in Boston, Massachusetts, United States.
What does Decibel Therapeutics do?
Decibel Therapeutics, Inc. is a pharmaceutical company. Its SEC industry classification is Pharmaceutical Preparations.
When was Decibel Therapeutics founded?
The earliest incorporation on record for Decibel Therapeutics, Inc. is in 2013, according to public company registers.
Similar companies
- Transcode Therapeutics, Inc.Boston, Massachusetts, United States
- Akouos, Inc.Boston, Massachusetts, United States
- Astria Therapeutics, Inc.Boston, Massachusetts, United States
- Albireo Pharma, Inc.Boston, Massachusetts, United States
- Atea Pharmaceuticals, Inc.Boston, Massachusetts, United States
- Rhythm Pharmaceuticals, Inc.Boston, Massachusetts, United States
- Tango Therapeutics, Inc.Boston, Massachusetts, United States
- Paratek Pharmaceuticals, Inc.Boston, Massachusetts, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-25. Data licences